⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

PPCB News

Propanc Biopharma, Inc. Common Stock

Propanc Reports End of Fiscal Year Highlights and Outlines Therapeutic Development & $100M+ Digital Asset Treasury Strategy